Case File
efta-02528501DOJ Data Set 11OtherEFTA02528501
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02528501
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Jeffrey Epstein <[email protected]>
Sent:
Saturday, February 27, 2010 7:43 PM
To:
jp
Subject:
Fwd: 01901 - LS1 finish samples
did you see this
Forwarded mes=age
From: Kristen Goff <
Date: Fri, Feb 26, 2010 at 6:01 PM
Subject: RE: 01901 - LSJ finish sampl=s
To: Jeffrey Epstein <[email protected] <mailto:[email protected]»
Cc: JPM Office
Unfor=unately, the earliest we can send them from Paris is Wednesday. If there is any way we can expedite the
shipment we will cert=inly do so.
</roan>
Best,=/span>
Krist=n
</=pan>
From: =span style="font-size:l0.Opt"> Jeffrey Epstein [mailto:[email protected] <mailto:[email protected]>
Sent: Friday, February 26, 2010 5:34 PM
To: Kristen Goff
Subject: Re: 01901 - LSJ finish samples
they must be here on =hurl. please try to send tues
On Fri, Feb 26, 2010 at 4:48 PM, Kristen Goff <
wrote:
Hello Mr. Epstein,
The 6 finish samples, =hich includes the sample prepared last week, will be sent to you from Paris Wednesday evening
via FedEx. Please let us know when you receive the samples.
EFTA_R1_01670176
EFTA02528501
Best,
The information contained in this communication is confidential, may be attorney-client privileged, may constitute
inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized
use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you
have received this communication in error, please notify us immediately by return e-mail or by e-mail to
[email protected] <mailto:[email protected]> , and destroy this communication and all copies thereof,
including all attachments.
The information contained in this communication ns confidential, may be attorney-client privileged, may constitute
in=ide information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unau=horized
use, disclosure or copying of this communication or any part th=reof is strictly prohibited and may be unlawful. If you
have received t=is communication in error, please notify us immediately by return e-mail or=by e-mail to
[email protected]= <mailto:[email protected]> , and destroy this communication and all copies thereof,
includi=g all attachments.
2
EFTA_R1_01670177
EFTA02528502
Technical Artifacts (6)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Email
[email protected]Email
[email protected]Email
[email protected]Phone
2528501Phone
2528502Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.